US20040159575A1 - Access resistant envelope - Google Patents
Access resistant envelope Download PDFInfo
- Publication number
 - US20040159575A1 US20040159575A1 US10/032,845 US3284501A US2004159575A1 US 20040159575 A1 US20040159575 A1 US 20040159575A1 US 3284501 A US3284501 A US 3284501A US 2004159575 A1 US2004159575 A1 US 2004159575A1
 - Authority
 - US
 - United States
 - Prior art keywords
 - oriented nylon
 - envelope
 - layer
 - nylon layers
 - layers
 - Prior art date
 - Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
 - Abandoned
 
Links
- 239000004677 Nylon Substances 0.000 claims abstract description 34
 - 229920001778 nylon Polymers 0.000 claims abstract description 34
 - XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims abstract description 10
 - 229910052782 aluminium Inorganic materials 0.000 claims abstract description 10
 - 238000007789 sealing Methods 0.000 claims abstract description 10
 - 229940119073 medicated pad Drugs 0.000 claims abstract description 5
 - 239000000463 material Substances 0.000 claims description 23
 - 238000000034 method Methods 0.000 claims description 15
 - 239000003814 drug Substances 0.000 claims description 6
 - 229940079593 drug Drugs 0.000 claims description 5
 - 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims description 5
 - -1 polyethylene Polymers 0.000 claims description 5
 - ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 4
 - 239000004698 Polyethylene Substances 0.000 claims description 4
 - YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 claims description 4
 - 229940127554 medical product Drugs 0.000 claims description 4
 - OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 claims description 4
 - 229920002239 polyacrylonitrile Polymers 0.000 claims description 4
 - 229920000573 polyethylene Polymers 0.000 claims description 4
 - 239000004480 active ingredient Substances 0.000 claims description 3
 - 229920006242 ethylene acrylic acid copolymer Polymers 0.000 claims description 3
 - DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims description 2
 - 241000723346 Cinnamomum camphora Species 0.000 claims description 2
 - 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 claims description 2
 - 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 claims description 2
 - 229940124599 anti-inflammatory drug Drugs 0.000 claims description 2
 - 229960000846 camphor Drugs 0.000 claims description 2
 - 229930008380 camphor Natural products 0.000 claims description 2
 - 229960002504 capsaicin Drugs 0.000 claims description 2
 - 235000017663 capsaicin Nutrition 0.000 claims description 2
 - 229960001047 methyl salicylate Drugs 0.000 claims description 2
 - 229960003742 phenol Drugs 0.000 claims description 2
 - 230000003637 steroidlike Effects 0.000 claims description 2
 - 239000003589 local anesthetic agent Substances 0.000 claims 1
 - 229940117841 methacrylic acid copolymer Drugs 0.000 claims 1
 - 239000004033 plastic Substances 0.000 claims 1
 - 229920003023 plastic Polymers 0.000 claims 1
 - 238000004519 manufacturing process Methods 0.000 abstract description 12
 - 239000002966 varnish Substances 0.000 abstract description 7
 - NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 abstract description 3
 - 229960004194 lidocaine Drugs 0.000 abstract description 2
 - 239000002131 composite material Substances 0.000 abstract 1
 - 230000007613 environmental effect Effects 0.000 abstract 1
 - 229920006395 saturated elastomer Polymers 0.000 abstract 1
 - 239000010410 layer Substances 0.000 description 54
 - 239000012790 adhesive layer Substances 0.000 description 11
 - 229920005648 ethylene methacrylic acid copolymer Polymers 0.000 description 6
 - 238000004806 packaging method and process Methods 0.000 description 6
 - 239000011247 coating layer Substances 0.000 description 4
 - 239000000126 substance Substances 0.000 description 3
 - 238000013459 approach Methods 0.000 description 2
 - BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 2
 - 230000015556 catabolic process Effects 0.000 description 2
 - 230000000052 comparative effect Effects 0.000 description 2
 - 239000002537 cosmetic Substances 0.000 description 2
 - JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
 - CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
 - 238000012986 modification Methods 0.000 description 2
 - 230000004048 modification Effects 0.000 description 2
 - 239000005022 packaging material Substances 0.000 description 2
 - 239000011241 protective layer Substances 0.000 description 2
 - 238000012360 testing method Methods 0.000 description 2
 - 230000000699 topical effect Effects 0.000 description 2
 - CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
 - UFLGIAIHIAPJJC-UHFFFAOYSA-N Tripelennamine Chemical compound C=1C=CC=NC=1N(CCN(C)C)CC1=CC=CC=C1 UFLGIAIHIAPJJC-UHFFFAOYSA-N 0.000 description 1
 - 239000000853 adhesive Substances 0.000 description 1
 - 230000001070 adhesive effect Effects 0.000 description 1
 - 229940125715 antihistaminic agent Drugs 0.000 description 1
 - 239000000739 antihistaminic agent Substances 0.000 description 1
 - 229960005274 benzocaine Drugs 0.000 description 1
 - 229960002537 betamethasone Drugs 0.000 description 1
 - UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 description 1
 - QRZAKQDHEVVFRX-UHFFFAOYSA-N biphenyl-4-ylacetic acid Chemical compound C1=CC(CC(=O)O)=CC=C1C1=CC=CC=C1 QRZAKQDHEVVFRX-UHFFFAOYSA-N 0.000 description 1
 - 229960000590 celecoxib Drugs 0.000 description 1
 - RZEKVGVHFLEQIL-UHFFFAOYSA-N celecoxib Chemical compound C1=CC(C)=CC=C1C1=CC(C(F)(F)F)=NN1C1=CC=C(S(N)(=O)=O)C=C1 RZEKVGVHFLEQIL-UHFFFAOYSA-N 0.000 description 1
 - 238000006243 chemical reaction Methods 0.000 description 1
 - 229960001747 cinchocaine Drugs 0.000 description 1
 - PUFQVTATUTYEAL-UHFFFAOYSA-N cinchocaine Chemical compound C1=CC=CC2=NC(OCCCC)=CC(C(=O)NCCN(CC)CC)=C21 PUFQVTATUTYEAL-UHFFFAOYSA-N 0.000 description 1
 - 239000000470 constituent Substances 0.000 description 1
 - 238000010276 construction Methods 0.000 description 1
 - 239000006071 cream Substances 0.000 description 1
 - 238000006731 degradation reaction Methods 0.000 description 1
 - 229960003957 dexamethasone Drugs 0.000 description 1
 - UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
 - 229960001259 diclofenac Drugs 0.000 description 1
 - DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
 - 229960000520 diphenhydramine Drugs 0.000 description 1
 - ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
 - 229940126534 drug product Drugs 0.000 description 1
 - 230000009977 dual effect Effects 0.000 description 1
 - 230000002500 effect on skin Effects 0.000 description 1
 - 230000001747 exhibiting effect Effects 0.000 description 1
 - 229960000192 felbinac Drugs 0.000 description 1
 - 229960002390 flurbiprofen Drugs 0.000 description 1
 - SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 1
 - 239000000499 gel Substances 0.000 description 1
 - 229960000890 hydrocortisone Drugs 0.000 description 1
 - 229960000905 indomethacin Drugs 0.000 description 1
 - DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
 - 229960000991 ketoprofen Drugs 0.000 description 1
 - 229940060977 lidoderm Drugs 0.000 description 1
 - 229940066974 medicated patch Drugs 0.000 description 1
 - 239000000203 mixture Substances 0.000 description 1
 - 229960002009 naproxen Drugs 0.000 description 1
 - CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
 - 239000002674 ointment Substances 0.000 description 1
 - 229940052264 other local anesthetics in atc Drugs 0.000 description 1
 - 238000007254 oxidation reaction Methods 0.000 description 1
 - 238000012858 packaging process Methods 0.000 description 1
 - 239000000825 pharmaceutical preparation Substances 0.000 description 1
 - 229920006267 polyester film Polymers 0.000 description 1
 - 238000012545 processing Methods 0.000 description 1
 - 229960000371 rofecoxib Drugs 0.000 description 1
 - RZJQGNCSTQAWON-UHFFFAOYSA-N rofecoxib Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1=C(C=2C=CC=CC=2)C(=O)OC1 RZJQGNCSTQAWON-UHFFFAOYSA-N 0.000 description 1
 - 238000001179 sorption measurement Methods 0.000 description 1
 - 239000003826 tablet Substances 0.000 description 1
 - 229960002372 tetracaine Drugs 0.000 description 1
 - GKCBAIGFKIBETG-UHFFFAOYSA-N tetracaine Chemical compound CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 GKCBAIGFKIBETG-UHFFFAOYSA-N 0.000 description 1
 - 229960005294 triamcinolone Drugs 0.000 description 1
 - GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 description 1
 - 229960003223 tripelennamine Drugs 0.000 description 1
 - 239000000341 volatile oil Substances 0.000 description 1
 
Images
Classifications
- 
        
- B—PERFORMING OPERATIONS; TRANSPORTING
 - B32—LAYERED PRODUCTS
 - B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
 - B32B15/00—Layered products comprising a layer of metal
 - B32B15/04—Layered products comprising a layer of metal comprising metal as the main or only constituent of a layer, which is next to another layer of the same or of a different material
 - B32B15/08—Layered products comprising a layer of metal comprising metal as the main or only constituent of a layer, which is next to another layer of the same or of a different material of synthetic resin
 
 - 
        
- B—PERFORMING OPERATIONS; TRANSPORTING
 - B32—LAYERED PRODUCTS
 - B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
 - B32B15/00—Layered products comprising a layer of metal
 - B32B15/20—Layered products comprising a layer of metal comprising aluminium or copper
 
 - 
        
- B—PERFORMING OPERATIONS; TRANSPORTING
 - B32—LAYERED PRODUCTS
 - B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
 - B32B27/00—Layered products comprising a layer of synthetic resin
 - B32B27/32—Layered products comprising a layer of synthetic resin comprising polyolefins
 
 - 
        
- B—PERFORMING OPERATIONS; TRANSPORTING
 - B32—LAYERED PRODUCTS
 - B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
 - B32B27/00—Layered products comprising a layer of synthetic resin
 - B32B27/34—Layered products comprising a layer of synthetic resin comprising polyamides
 
 - 
        
- B—PERFORMING OPERATIONS; TRANSPORTING
 - B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
 - B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
 - B65B9/00—Enclosing successive articles, or quantities of material, e.g. liquids or semiliquids, in flat, folded, or tubular webs of flexible sheet material; Subdividing filled flexible tubes to form packages
 - B65B9/02—Enclosing successive articles, or quantities of material between opposed webs
 
 - 
        
- B—PERFORMING OPERATIONS; TRANSPORTING
 - B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
 - B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
 - B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes or webs of flexible sheet material, e.g. in folded wrappers
 - B65D75/40—Packages formed by enclosing successive articles, or increments of material, in webs, e.g. folded or tubular webs, or by subdividing tubes filled with liquid, semi-liquid, or plastic materials
 - B65D75/44—Individual packages cut from webs or tubes
 - B65D75/46—Individual packages cut from webs or tubes containing articles
 
 - 
        
- B—PERFORMING OPERATIONS; TRANSPORTING
 - B32—LAYERED PRODUCTS
 - B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
 - B32B2307/00—Properties of the layers or laminate
 - B32B2307/50—Properties of the layers or laminate having particular mechanical properties
 - B32B2307/514—Oriented
 
 - 
        
- B—PERFORMING OPERATIONS; TRANSPORTING
 - B32—LAYERED PRODUCTS
 - B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
 - B32B2439/00—Containers; Receptacles
 - B32B2439/80—Medical packaging
 
 
Definitions
- This invention relates to packaging approaches for medical products, particularly medicated dermal pads.
 - Access-resistant packages involving bottles and tubes containing tablets, gels, creams, ointments and the like are well known. However, for products not easily housed in such containers, few options are available.
 - the present invention meets this need by providing an access-resistant envelop. It conveniently serves the dual purposes of basic packaging and a safety system, especially for such things as topical patch-type drug products, topical cosmetics, and medical devices.
 - the present invention includes tamper or access resistant envelopes or packages. It especially contemplates packaging for medicated pads constructed in such a way to avoid access by hands or teeth, particularly human hands or teeth.
 - the inventive package is constructed so the only practicable method of opening it is with a cutter such as scissors or a knife. Accordingly, it is believed that the present invention will meet or exceed the child resistance and consumer product safety standards of the U.S. and various other countries, thereby satisfying a serious need.
 - the package comprises two heat-sealed panels or sides, one or both of them made of multiple layers including at least an outer printable layer and a pair of oriented nylon layers.
 - print and a varnish coat layer is provided on the facing surfaces and an aluminum layer, sometimes a polyacrylonitrile (PAN) layer is provided on the inside of each panel.
 - PAN polyacrylonitrile
 - the invention includes methods of producing the packaged combination of a pad and the access resistant package, the combination itself and the package itself. It further includes such variations as would be apparent to one with skill in the art.
 - FIG. 1 shows an overview of the invention.
 - FIG. 2A and 2B schematically illustrate production line elements for assembling the present invention.
 - product according to the present invention including an envelope 2 and at least one medicated pad or patch 4 is shown.
 - the envelope comprises a first panel 6 and a second panel 8 .
 - the first panel is shown with its constituent parts splayed apart.
 - the second panel is preferably similarly constructed.
 - two pads 4 are shown going into envelope 2 , each package typically contains anywhere from one to five pads or patches.
 - An exemplary pad for inclusion in the package is sold as the Endo Laboratories LIDODERM® patch available through Endo Pharmaceuticals, Inc. (Chadds Ford, Pa.: U.S.A.) and manufactured by Teikoku Seiyaku Co. Ltd (Sanbonmatsu, Kagawa: Japan), the latter being the assignee of the present invention. It is a 5% strength patch utilizing 700 mg lidocaine in an aqueous base.
 - Suitable active ingredient(s) other local anesthetics, e.g., Benzocaine, Dibucaine, Tetracaine; steroidal anti inflammatory drugs, e.g., Hydrocortisone, Predonisolone, Dexamethasone, Triamcinolone or Betamethasone; COX-2 specific non steroidal anti inflammatory drugs (NSAIDs), e.g., Celecoxib or Rofecoxib; other NSAIDs, e.g., Acetoaminophen, Ketoprofen, Flurbiprofen, Felbinac, Diclofenac, Indomethacin, Naproxen; antihistamines, e.g., Diphenhydramine or Tripelennamine; or other drugs such as Capsaicin, Methyl salicylate, Camphor or Phenol.
 - active ingredients may be carried as in the exemplary patch, by a gel-type medium or otherwise.
 - the package panels are preferably joined around the periphery through heat sealing.
 - the outer margin 10 demarcated by lines 12 are joined in a finished package 2 .
 - Line breaks 14 are indicative of a region that may initially left open or unsealed so that a sealing or resealing mechanism 16 can be inserted and then sealed in place as is preferred.
 - the sealing mechanism is preferably a ZIPLOC® type seal with outer members 18 able to capture and release an inner member 20 .
 - the sealing mechanism is important in situations where a volatile product, such as the referenced pad is to remain in the package after it is initially opened in the region above the seal.
 - the sealing member allows for conveniently resealing the pouch to preserve content's efficacy (or freshness in the case of perishables stored therein).
 - the sealing mechanism is preferably omitted and the envelope sealed around the entire periphery as easily accomplished by the manufacturing techniques described below.
 - Either one or both of the panels comprise a number of material layers. Most preferably, the following layers are contemplated. Broadly speaking, such a package usually employs an inside layer 22 , an aluminum layer 24 , at least two oriented nylon layers 26 , and cosmetic external layers 28 , preferably comprising a layer 30 upon which print is applied and a print-protective layer 32 . Between adjacent primary layers, adhesive layers 34 are employed. The adhesives used may by of any sort normally used to adhere packaging materials. It may, however, be desired to use a layer of polyethylene (PE) to seal adjoining layers upon the application of heat as further described below.
 - PE polyethylene
 - inside layer 22 comes into direct contact with the packaged product. During manufacture, it is preferably melted and adhered to an opposing panel layer by heat sealing in the packaging process.
 - layer 22 may comprise PE, ethylene methacrylic acid copolymer (EMAA), or ethylene acrylic acid copolymer (EAA).
 - EAA ethylene methacrylic acid copolymer
 - PAN can be used on or as the inside layer to moderate adsorption of the volatile substance.
 - the next major layer 24 is an optional aluminum layer. Such a layer contributes to the stability of the packaged contents. It is substantially gas and light impermeable so as to shield package contents 4 from the external environment and associated degradation (e.g., oxidization, other reaction or chemical breakdown).
 - one or more resistance medium layers 26 are provided. Most preferably, at least two medium layers comprising oriented nylon are provided. This material is both flexible and tough and (especially when taken together) is extremely resistant to opening by human hands or teeth.
 - external layers 28 may comprise a printed layer 30 and a protective layer 32 .
 - Layer 30 may comprise paper, a polyester film, or another material, especially one with is easily printed upon. Any number of approaches may be taken toward printing as would be apparent to those with skill in the art. If applied, especially to protect the print, layer 30 may comprise varnish as is commonly used for such applications.
 - overall panel thickness is limited to facilitate processing with standard production line machinery.
 - the total thickness of the layers on each side of package 2 are less than about 200 ⁇ m thick since greater thickness may prohibit manufacture using modified common heat sealing machinery.
 - a total of 4 oriented nylon plies of material are employed in the package, they are preferably each between about 20 and 45 ⁇ m thick to facilitate manufacturing, while still exhibiting sufficient strength.
 - FIGS. 2A and 2B show portions of a manufacturing line adapted to produce the inventive package.
 - a packaged combination of pad(s) and the envelope or bag is prepared by supplying pads 4 by a conveyer 34 and material for panels 6 and 8 in a continuous web, e.g,. in sheets or as unrolled from a spool.
 - These webbing pieces 54 may be layed-up in advance and fed from a single feed roll as shown or each panel layer may be provided by separate feed rollers or as otherwise convenient.
 - the layers of panel material may ultimately be fully laminated together or laminated around a periphery. In either case, they may be referred to as a “laminate.”
 - the joined web 46 of partially trimmed material progresses until it encounters vertical heat cutters 48 . From this point, finished product 50 is transported to bulk packaging by a second conveyer 52 .
 - the oriented nylon plies of a given side of the package preferably have a grain or orientation aligned (i.e., placed substantially parallel) with one another.
 - a grain or orientation aligned i.e., placed substantially parallel
 - rip or slip properties normally associated with oriented nylon packages are, surprisingly, not observed.
 - Oriented nylon is actually often chosen for packaging material since packages using one layer of material on each side that is joined around the package periphery is easy torn open once a small rip is started.
 - the material grain of the sheets of oriented nylon are aligned with one another, it might be thought that similar tear propagation might occur.
 - the task set for the test was to open a pouch given 5 minutes without any tools. Using only their hands and teeth, 2 out of 20 grown men were able to open the second pouch. However, none were able to open the first pouch using multiple plies of oriented nylon material on each side. Both are easily opened with scissors or another cutting implement.
 
Landscapes
- Engineering & Computer Science (AREA)
 - Mechanical Engineering (AREA)
 - Packages (AREA)
 
Abstract
A human resistance pharmaceutical package is described. A package is provided in which access to a medicated pad, such as one saturated with Lidocaine, is obstructed unless opening is attempted using a cutting tool. The package is made from two heat-sealed panels. At least one of the panels is made of multiple layers including at least an outer printable layer and a pair of oriented nylon layers. Preferably, print and a varnish coat layer is provided on the facing surfaces. Aluminum layers may provide environmental protection for package contents. Usually, panel thickness will be limited for use with standard production line machinery. Together, the composite layers are preferably not so thick as to prohibit the use of common heat sealing machinery or modified typical machinery for production. 
  Description
-  This invention relates to packaging approaches for medical products, particularly medicated dermal pads.
 -  In recent years, a greater focus has been placed on safety issues associated with product packaging. Particularly with respect to drugs and foodstuffs, tamper resistant and child-resistant packaging is often either mandatory or at least practically required to sell product. For drugs, protecting against inadvertent access, however it might occur, is also important.
 -  Access-resistant packages involving bottles and tubes containing tablets, gels, creams, ointments and the like are well known. However, for products not easily housed in such containers, few options are available. The present invention meets this need by providing an access-resistant envelop. It conveniently serves the dual purposes of basic packaging and a safety system, especially for such things as topical patch-type drug products, topical cosmetics, and medical devices.
 -  The present invention includes tamper or access resistant envelopes or packages. It especially contemplates packaging for medicated pads constructed in such a way to avoid access by hands or teeth, particularly human hands or teeth. The inventive package is constructed so the only practicable method of opening it is with a cutter such as scissors or a knife. Accordingly, it is believed that the present invention will meet or exceed the child resistance and consumer product safety standards of the U.S. and various other countries, thereby satisfying a serious need.
 -  The package comprises two heat-sealed panels or sides, one or both of them made of multiple layers including at least an outer printable layer and a pair of oriented nylon layers. Preferably, print and a varnish coat layer is provided on the facing surfaces and an aluminum layer, sometimes a polyacrylonitrile (PAN) layer is provided on the inside of each panel.
 -  The invention includes methods of producing the packaged combination of a pad and the access resistant package, the combination itself and the package itself. It further includes such variations as would be apparent to one with skill in the art.
 -  Each of the following figures provide examples diagrammatically illustrating aspects of the present invention.
 -  FIG. 1 shows an overview of the invention.
 -  FIG. 2A and 2B schematically illustrate production line elements for assembling the present invention.
 -  Before the present invention is described in detail, it is to be understood that this invention is not limited to the particular variations set forth and may, of course, vary. Various changes may be made to the invention described and equivalents may be substituted without departing from the true spirit and scope of the invention. In addition, many modifications may be made to adapt a particular situation, material, composition of matter, process, process step or steps to the objective, spirit and scope of the present invention. All such modifications are intended to be within the scope of the claims made herein. Furthermore, where a range of values is provided, it is understood that every intervening value, between the upper and lower limit of that range and any other stated or intervening value in that stated range is encompassed within the invention. That the upper and lower limits of these smaller ranges may independently be included in the smaller ranges is also encompassed within the invention, subject to any specifically excluded limit in the stated range. Where the stated range includes one or both of the limits, ranges excluding either both of those included limits are also included in the invention.
 -  Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although any methods and materials similar or equivalent to those described herein can also be used in the practice or testing of the present invention, the preferred methods and materials are now described. All publications, patents and patent applications mentioned herein are incorporated herein in their entirety. The referenced items are provided solely for their disclosure prior to the filing date of the present application. Nothing herein is to be construed as an admission that the present invention is not entitled to antedate such material by virtue of prior invention.
 -  It is also noted that as used herein and in the appended claims, the singular forms “a,” “and,” and “the” include plural referents unless the context clearly dictates otherwise. In the claims, the terms “first,” “second” and so forth are to be interpreted merely as ordinal designations, they shall not be limiting in themselves. Further, the use of exclusive terminology such as “solely,” “only” and the like in connection with the recitation of any claim element is contemplated. Also, it is contemplated that any element indicated to be optional herein may be specifically excluded from a given claim by way of a “negative” limitation. Finally, it is contemplated that any optional feature of the inventive variation(s) described herein may be set forth and claimed independently or in combination with any one or more of the features described herein.
 -  Turning now to FIG. 1, product according to the present invention including an
envelope 2 and at least one medicated pad orpatch 4 is shown. The envelope comprises afirst panel 6 and asecond panel 8. The first panel is shown with its constituent parts splayed apart. The second panel is preferably similarly constructed. Though twopads 4 are shown going intoenvelope 2, each package typically contains anywhere from one to five pads or patches. -  An exemplary pad for inclusion in the package is sold as the Endo Laboratories LIDODERM® patch available through Endo Pharmaceuticals, Inc. (Chadds Ford, Pa.: U.S.A.) and manufactured by Teikoku Seiyaku Co. Ltd (Sanbonmatsu, Kagawa: Japan), the latter being the assignee of the present invention. It is a 5% strength patch utilizing 700 mg lidocaine in an aqueous base. Other potential active ingredient(s) other local anesthetics, e.g., Benzocaine, Dibucaine, Tetracaine; steroidal anti inflammatory drugs, e.g., Hydrocortisone, Predonisolone, Dexamethasone, Triamcinolone or Betamethasone; COX-2 specific non steroidal anti inflammatory drugs (NSAIDs), e.g., Celecoxib or Rofecoxib; other NSAIDs, e.g., Acetoaminophen, Ketoprofen, Flurbiprofen, Felbinac, Diclofenac, Indomethacin, Naproxen; antihistamines, e.g., Diphenhydramine or Tripelennamine; or other drugs such as Capsaicin, Methyl salicylate, Camphor or Phenol. Such active ingredients may be carried as in the exemplary patch, by a gel-type medium or otherwise.
 -  The package panels are preferably joined around the periphery through heat sealing. The
outer margin 10 demarcated bylines 12 are joined in a finishedpackage 2.Line breaks 14 are indicative of a region that may initially left open or unsealed so that a sealing or resealingmechanism 16 can be inserted and then sealed in place as is preferred. The sealing mechanism is preferably a ZIPLOC® type seal withouter members 18 able to capture and release aninner member 20. -  The sealing mechanism is important in situations where a volatile product, such as the referenced pad is to remain in the package after it is initially opened in the region above the seal. The sealing member allows for conveniently resealing the pouch to preserve content's efficacy (or freshness in the case of perishables stored therein). Where only one single-
use pad 4 is to be included in the envelope, the sealing mechanism is preferably omitted and the envelope sealed around the entire periphery as easily accomplished by the manufacturing techniques described below. -  Either one or both of the panels comprise a number of material layers. Most preferably, the following layers are contemplated. Broadly speaking, such a package usually employs an
inside layer 22, analuminum layer 24, at least twooriented nylon layers 26, and cosmeticexternal layers 28, preferably comprising alayer 30 upon which print is applied and a print-protective layer 32. Between adjacent primary layers,adhesive layers 34 are employed. The adhesives used may by of any sort normally used to adhere packaging materials. It may, however, be desired to use a layer of polyethylene (PE) to seal adjoining layers upon the application of heat as further described below. -  Typically, inside
layer 22 comes into direct contact with the packaged product. During manufacture, it is preferably melted and adhered to an opposing panel layer by heat sealing in the packaging process. In such instances,layer 22 may comprise PE, ethylene methacrylic acid copolymer (EMAA), or ethylene acrylic acid copolymer (EAA). In cases were the packaged products include a volatile substance such as a volatile oil, PAN can be used on or as the inside layer to moderate adsorption of the volatile substance. -  The next
major layer 24 is an optional aluminum layer. Such a layer contributes to the stability of the packaged contents. It is substantially gas and light impermeable so as to shieldpackage contents 4 from the external environment and associated degradation (e.g., oxidization, other reaction or chemical breakdown). -  Further, one or more resistance
medium layers 26 are provided. Most preferably, at least two medium layers comprising oriented nylon are provided. This material is both flexible and tough and (especially when taken together) is extremely resistant to opening by human hands or teeth. -  As stated above,
external layers 28 may comprise a printedlayer 30 and aprotective layer 32.Layer 30 may comprise paper, a polyester film, or another material, especially one with is easily printed upon. Any number of approaches may be taken toward printing as would be apparent to those with skill in the art. If applied, especially to protect the print,layer 30 may comprise varnish as is commonly used for such applications. -  Usually, overall panel thickness is limited to facilitate processing with standard production line machinery. Together, the total thickness of the layers on each side of
package 2 are less than about 200 μm thick since greater thickness may prohibit manufacture using modified common heat sealing machinery. Where a total of 4 oriented nylon plies of material are employed in the package, they are preferably each between about 20 and 45 μm thick to facilitate manufacturing, while still exhibiting sufficient strength. -  Where only one pair of oriented nylon layers is used (on either side or one on each), the material may be twice as thick without causing manufacturing difficulties. It is most preferred, however, that the package is constructed with at least two oriented nylon plies on each side of the package. Regardless, FIGS. 2A and 2B show portions of a manufacturing line adapted to produce the inventive package.
 -  As shown in FIG. 2A, a packaged combination of pad(s) and the envelope or bag is prepared by supplying
pads 4 by aconveyer 34 and material for 6 and 8 in a continuous web, e.g,. in sheets or as unrolled from a spool. Thesepanels webbing pieces 54 may be layed-up in advance and fed from a single feed roll as shown or each panel layer may be provided by separate feed rollers or as otherwise convenient. The layers of panel material may ultimately be fully laminated together or laminated around a periphery. In either case, they may be referred to as a “laminate.” -  The panel material and pad(s) are brought into proximity of one another before the panel material is cut along the
horizontal sides 36 by heat-cutter type rollers 38. Following this,horizontal heat sealers 40 in close proximity to the webbing pieces heat the material. Then,rollers 56 compress the material together to securely bond them. Next,vertical heat sealers 42 are actuated to seal thevertical sides 44 of the envelope as now-joined material continues through the production line. -  As shown in FIG. 2B, the joined
web 46 of partially trimmed material progresses until it encountersvertical heat cutters 48. From this point,finished product 50 is transported to bulk packaging by asecond conveyer 52. -  For ease of manufacturing and material handling, the oriented nylon plies of a given side of the package preferably have a grain or orientation aligned (i.e., placed substantially parallel) with one another. When the layers of material are oriented thus, rip or slip properties normally associated with oriented nylon packages are, surprisingly, not observed. Oriented nylon is actually often chosen for packaging material since packages using one layer of material on each side that is joined around the package periphery is easy torn open once a small rip is started. In the four-ply oriented nylon pouches according to the present invention, where the material grain of the sheets of oriented nylon are aligned with one another, it might be thought that similar tear propagation might occur.
 -  However, comparative results shown otherwise. A pouch like that described above using two 25 μm oriented nylon layers (oriented in the same direction) for each side was compared to a pouch using only one 50 μm layer on each side. The overall construction of the pouches compared were as follows:
Front Side Laminate Back Side Laminate Inventive Package Example: (Outside) (Inside) Varnish Coating layer EMAA layer (18 μm) Printed Paper layer Aluminum layer (7 μm) Adhesive layer Adhesive layer Oriented Nylon layer (25 μm) Oriented Nylon layer (25 μm) Adhesive layer Adhesive layer Oriented Nylon layer (25 μm) Oriented Nylon layer (25 μm) Adhesive layer Adhesive layer Aluminum layer (7 μm) Printed Paper layer EMAA layer (18 μm) Varnish Coating layer (Inside) (Outside) Comparative Package Example: (Outside) (Inside) Varnish Coating layer EMAA layer (18 μm) Printed Paper layer Aluminum layer (7 μm) Adhesive layer Adhesive layer Oriented Nylon layer (50 μm) Oriented Nylon layer (50 μm) Adhesive layer Adhesive layer Aluminum layer (7 μm) Printed Paper layer EMAA layer (18 μm) Varnish Coating layer (Inside) (Outside)  -  With these pouches, the task set for the test was to open a pouch given 5 minutes without any tools. Using only their hands and teeth, 2 out of 20 grown men were able to open the second pouch. However, none were able to open the first pouch using multiple plies of oriented nylon material on each side. Both are easily opened with scissors or another cutting implement.
 -  Though the invention has been described in reference to a single example, optionally incorporating various features, the invention is not to be limited to the set-up described. It is to be understood that the breadth of the present invention is to be limited only by the literal or equitable scope of the claims.
 
Claims (16)
 1. An access resistant envelope comprising: 
    a first panel and a second panel, at least one of said panels in the form of a laminate comprising a plurality of oriented nylon layers. 
  2. The envelope of claim 1 , wherein said plurality of oriented nylon layers is a pair of oriented nylon layers. 
     3. The envelope of claim 1 , wherein both of said panels are in the form of a laminate comprising a plurality of oriented nylon layers. 
     4. The envelope of claim 3 , wherein each plurality of oriented nylon layers is a pair of oriented nylon layers, thereby providing 4 oriented nylon layers. 
     5. The envelope of claim 4 , wherein each oriented nylon layers is between about 20 to 45 μm thick. 
     6. The envelope of claim 1 , wherein said at least one panel in the form of a laminate further comprises an external printable layer and an internal aluminum layer. 
     7. The envelope of claim 1 , wherein both of said panels are in the form of a laminate further comprises an external printable layer and an internal aluminum layer. 
     8. An access resistant medical product envelope comprising an access resistant envelope as described in claim 1  containing at least one medicated pad. 
     9. The medical product envelope of claim 8 , wherein said at least one medicated pad includes an active ingredient selected from a group of drugs consisting of local anesthetic drugs, steroidal anti inflammatory drugs, non steroidal anti inflammatory drugs, COX-2 specific non steroidal anti inflammatory drugs, Capsaicin, Methyl salicylate, Camphor and Phenol. 
     10. An access resistant medical product envelope made by a method comprising: 
    providing a medicated pad having first and second sides, and webbing pieces on each of said pad sides, wherein at least one of said webbing pieces comprises a plurality of oriented nylon layers; 
 sealing said webbing pieces together to form a periphery around said pad; and 
 cutting said envelope from said webbing pieces sealed together. 
  11. The method of claim 10 , wherein two oriented nylon layers are provided. 
     12. The method of claim 11 , wherein said two oriented nylon layers are aligned in orientation. 
     13. The method of claim 10 , wherein four oriented nylon layers are provided. 
     14. The method of claim 11 , wherein said four oriented nylon layers are aligned in orientation. 
     15. The method of claim 10 , wherein adjacent oriented nylon layer are thermally bonded together using a polyethylene layer. 
     16. The method of claim 10 , wherein said webbing pieces are thermally bonded using at least one layer of material selected from a group of plastics consisting of polyethylene, ethylene methacrylic acid copolymer, ethylene acrylic acid copolymer and polyacrylonitrile.
    Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| US10/032,845 US20040159575A1 (en) | 2001-12-26 | 2001-12-26 | Access resistant envelope | 
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| US10/032,845 US20040159575A1 (en) | 2001-12-26 | 2001-12-26 | Access resistant envelope | 
Publications (1)
| Publication Number | Publication Date | 
|---|---|
| US20040159575A1 true US20040159575A1 (en) | 2004-08-19 | 
Family
ID=32848801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date | 
|---|---|---|---|
| US10/032,845 Abandoned US20040159575A1 (en) | 2001-12-26 | 2001-12-26 | Access resistant envelope | 
Country Status (1)
| Country | Link | 
|---|---|
| US (1) | US20040159575A1 (en) | 
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| US20040168945A1 (en) * | 2002-12-27 | 2004-09-02 | Noven Pharmaceuticals, Inc. | Product retention package | 
| US20100264055A1 (en) * | 2009-04-20 | 2010-10-21 | Jordan Eisenberg | Portable Powder Delivery System and Method | 
| US20130262333A1 (en) * | 2012-03-27 | 2013-10-03 | Document Security Systems, Inc. | Systems and Methods for Identity Authentication Via Secured Chain of Custody of Verified Identity | 
| CN104010635A (en) * | 2011-09-09 | 2014-08-27 | Api起源有限责任公司 | Analgesic composition comprising TRPV1 selective agonist and its preparation and application | 
| CN104856879A (en) * | 2015-06-09 | 2015-08-26 | 李万红 | Dual-unit multi-group plaster application machine | 
Citations (21)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| US2760630A (en) * | 1954-12-08 | 1956-08-28 | Sterling Drug Inc | Foil covered ampoule | 
| US3503493A (en) * | 1968-01-08 | 1970-03-31 | Hoffmann La Roche | Medicament packaging device | 
| US3750907A (en) * | 1970-04-08 | 1973-08-07 | Eastman Kodak Co | Fluid containers having both relatively strong and relatively weak seals | 
| US3872970A (en) * | 1974-01-11 | 1975-03-25 | Lilly Co Eli | Child-resistant blister package | 
| US4011949A (en) * | 1975-06-18 | 1977-03-15 | The Lehigh Press, Inc. | Package construction for opening only by a predetermined procedure | 
| US4279344A (en) * | 1979-12-26 | 1981-07-21 | Reynolds Metals Company | Heat-sealable and peelable laminated packaging construction | 
| US4303751A (en) * | 1980-06-16 | 1981-12-01 | Polaroid Corporation | Rupturable photographic processing alkaline fluid container | 
| US4303750A (en) * | 1980-06-16 | 1981-12-01 | Polaroid Corporation | Alkaline fluid photographic processing composition containers | 
| US4784885A (en) * | 1986-08-29 | 1988-11-15 | R. J. Reynolds Tobacco Company | Peelable film laminate | 
| US5154789A (en) * | 1984-11-28 | 1992-10-13 | American National Can Company | Multiple layer films containing oriented layers of nylon and ethylene vinyl alcohol copolymers | 
| US5253754A (en) * | 1992-08-14 | 1993-10-19 | American Fluoroseal Corporation | Peel package and method of packaging organs | 
| US5273797A (en) * | 1987-01-08 | 1993-12-28 | Exxon Chemical Patents Inc. | Food package, retort lidding, and coextruded film therefor | 
| US5423737A (en) * | 1993-05-27 | 1995-06-13 | New Dimensions In Medicine, Inc. | Transparent hydrogel wound dressing with release tab | 
| US5505306A (en) * | 1993-07-19 | 1996-04-09 | Nitto Denko Corporation | Package structure of drug-containing pressure-sensitive adhesive sheet | 
| US5511665A (en) * | 1994-10-31 | 1996-04-30 | G. D. Searle & Co. | Child-resistant package | 
| US5700091A (en) * | 1995-09-04 | 1997-12-23 | Idemitsu Petrochemical Co., Ltd. | Snap fastener and a bag for packaging with a snap fastener | 
| US5837336A (en) * | 1995-12-01 | 1998-11-17 | Tdk Corporation | Film-wrapped articles with improved opening properties | 
| US6003670A (en) * | 1996-07-30 | 1999-12-21 | Fres-Co System Usa, Inc. | Abuse resistant flexible package | 
| US6066404A (en) * | 1995-04-05 | 2000-05-23 | Dai Nippon Printing Co., Ltd. | Packaging clean film and packaging pouch | 
| US6127024A (en) * | 1998-05-21 | 2000-10-03 | Morgan Adhesives Company | Single ply battery label including varnish with patterned edges | 
| US6199698B1 (en) * | 1999-12-03 | 2001-03-13 | Alusuisse Technology & Management, Ltd. | Pharmaceutical packaging with separation means | 
- 
        2001
        
- 2001-12-26 US US10/032,845 patent/US20040159575A1/en not_active Abandoned
 
 
Patent Citations (21)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| US2760630A (en) * | 1954-12-08 | 1956-08-28 | Sterling Drug Inc | Foil covered ampoule | 
| US3503493A (en) * | 1968-01-08 | 1970-03-31 | Hoffmann La Roche | Medicament packaging device | 
| US3750907A (en) * | 1970-04-08 | 1973-08-07 | Eastman Kodak Co | Fluid containers having both relatively strong and relatively weak seals | 
| US3872970A (en) * | 1974-01-11 | 1975-03-25 | Lilly Co Eli | Child-resistant blister package | 
| US4011949A (en) * | 1975-06-18 | 1977-03-15 | The Lehigh Press, Inc. | Package construction for opening only by a predetermined procedure | 
| US4279344A (en) * | 1979-12-26 | 1981-07-21 | Reynolds Metals Company | Heat-sealable and peelable laminated packaging construction | 
| US4303751A (en) * | 1980-06-16 | 1981-12-01 | Polaroid Corporation | Rupturable photographic processing alkaline fluid container | 
| US4303750A (en) * | 1980-06-16 | 1981-12-01 | Polaroid Corporation | Alkaline fluid photographic processing composition containers | 
| US5154789A (en) * | 1984-11-28 | 1992-10-13 | American National Can Company | Multiple layer films containing oriented layers of nylon and ethylene vinyl alcohol copolymers | 
| US4784885A (en) * | 1986-08-29 | 1988-11-15 | R. J. Reynolds Tobacco Company | Peelable film laminate | 
| US5273797A (en) * | 1987-01-08 | 1993-12-28 | Exxon Chemical Patents Inc. | Food package, retort lidding, and coextruded film therefor | 
| US5253754A (en) * | 1992-08-14 | 1993-10-19 | American Fluoroseal Corporation | Peel package and method of packaging organs | 
| US5423737A (en) * | 1993-05-27 | 1995-06-13 | New Dimensions In Medicine, Inc. | Transparent hydrogel wound dressing with release tab | 
| US5505306A (en) * | 1993-07-19 | 1996-04-09 | Nitto Denko Corporation | Package structure of drug-containing pressure-sensitive adhesive sheet | 
| US5511665A (en) * | 1994-10-31 | 1996-04-30 | G. D. Searle & Co. | Child-resistant package | 
| US6066404A (en) * | 1995-04-05 | 2000-05-23 | Dai Nippon Printing Co., Ltd. | Packaging clean film and packaging pouch | 
| US5700091A (en) * | 1995-09-04 | 1997-12-23 | Idemitsu Petrochemical Co., Ltd. | Snap fastener and a bag for packaging with a snap fastener | 
| US5837336A (en) * | 1995-12-01 | 1998-11-17 | Tdk Corporation | Film-wrapped articles with improved opening properties | 
| US6003670A (en) * | 1996-07-30 | 1999-12-21 | Fres-Co System Usa, Inc. | Abuse resistant flexible package | 
| US6127024A (en) * | 1998-05-21 | 2000-10-03 | Morgan Adhesives Company | Single ply battery label including varnish with patterned edges | 
| US6199698B1 (en) * | 1999-12-03 | 2001-03-13 | Alusuisse Technology & Management, Ltd. | Pharmaceutical packaging with separation means | 
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| US20040168945A1 (en) * | 2002-12-27 | 2004-09-02 | Noven Pharmaceuticals, Inc. | Product retention package | 
| US7044301B2 (en) * | 2002-12-27 | 2006-05-16 | Noven Pharmaceuticals, Inc. | Product positioning retention package | 
| US20100264055A1 (en) * | 2009-04-20 | 2010-10-21 | Jordan Eisenberg | Portable Powder Delivery System and Method | 
| WO2010123897A3 (en) * | 2009-04-20 | 2011-03-31 | Breakthrough Products, Inc. | Portable powder delivery system and method | 
| US8376140B2 (en) | 2009-04-20 | 2013-02-19 | Breakthrough Products, Inc. | Portable powder delivery system and method | 
| CN104010635A (en) * | 2011-09-09 | 2014-08-27 | Api起源有限责任公司 | Analgesic composition comprising TRPV1 selective agonist and its preparation and application | 
| US20130262333A1 (en) * | 2012-03-27 | 2013-10-03 | Document Security Systems, Inc. | Systems and Methods for Identity Authentication Via Secured Chain of Custody of Verified Identity | 
| CN104856879A (en) * | 2015-06-09 | 2015-08-26 | 李万红 | Dual-unit multi-group plaster application machine | 
Similar Documents
| Publication | Publication Date | Title | 
|---|---|---|
| US4387126A (en) | Laminated packaging material | |
| US6571983B1 (en) | Method and device for dispensing flat forms | |
| AU2011200489A1 (en) | Method for guided tearing of pouch laminate to enable product removal | |
| RU2563779C2 (en) | Packaging bag | |
| JP2009515786A (en) | Cold-formable laminate for blister base parts | |
| JP5822956B2 (en) | Multilayer film for low adsorptive laminate, composite film using the same, and packaging material | |
| US20140034524A1 (en) | Package having a tearable internal pouch provided with a rupturing means | |
| JP2606590Y2 (en) | Laminated material with good gas barrier properties | |
| JP6331116B2 (en) | Patch packaging structure | |
| US20040159575A1 (en) | Access resistant envelope | |
| US20080038415A1 (en) | Packaging Having A Weakening Area | |
| CA2878330C (en) | New single-dose packaging | |
| JP4449964B2 (en) | Standing pouch with a branched chamber | |
| JP6663206B2 (en) | Laminated films, packaging materials and bags | |
| AU8361101A (en) | Retortable pouch | |
| US20220274392A1 (en) | Laminate methods and products | |
| JPH04361038A (en) | Composite film for packing | |
| JP2011251729A (en) | Packaging bag | |
| IL115740A (en) | Childproof package for active substance patches and a process for the production thereof | |
| JP2006193196A (en) | Packaging material and infusion bag of infusion bag using the same | |
| WO2019093227A1 (en) | Cover material for blister packs | |
| US6936318B2 (en) | No tear pharmaceutical pouch | |
| JP4079123B2 (en) | Pouch with a branched chamber | |
| JP4480467B2 (en) | Laminated film for packaging, method for producing the same, and packaging bag | |
| JPH07165256A (en) | Film easy to tear | 
Legal Events
| Date | Code | Title | Description | 
|---|---|---|---|
| AS | Assignment | 
             Owner name: TEIKOKU PHARMA, USA, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SHUDO, JUTARO;UEMATSU, MASANORI;REEL/FRAME:012682/0159;SIGNING DATES FROM 20020204 TO 20020212  | 
        |
| STCB | Information on status: application discontinuation | 
             Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION  |